They could possibly get exposure to adapt thru’ distribution...

They could possibly get exposure to adapt thru’ distribution deal, way less costly.

That said, it would be interesting to see, would, say Edwards Life’s science etc promote at the expense of its own products.

You probably would need a major entity that has a minimal footprint (but with perhaps foresight to expand) in this market but the ability for them to distribute and be on a even footing with Edwards etc

I believe the shadow/drag/liability of the vaccine division would make take over unattractive,imo.

Whoever is selling down at the moment is seemingly not too confident on waiting another couple of quarters for a better return, we absolutely need the reverse scenario, interest by players that are confident!

Eleven months to go, if no sp appreciation to at least the forty cent range by end of year then I for one will be wondering what the heck is going on!